We followed 828 nondemented residents of Hisayama Town, Kyushu, Japan, aged 65 years or older (88.3% of the elderly population) for 7 years starting in 1985 in order to determine the type-specific incidence of dementia and its risk factors in the general Japanese population. Only two subjects were lost to the follow-up, during which period 103 subjects developed dementia. Morphologic examination of the brains of 89 subjects (86.4%) was made by autopsy or CT. We made the initial diagnosis of dementia based on the DSM-III-R criteria, with the diagnoses of vascular dementia (VD) being based on the NINDS-AIREN criteria and Alzheimer's disease (AD) on the NINCDS-ADRDA criteria. The incidence of VD and AD increased with age for both sexes. The age-adjusted total incidence (per 1,000 person-years) of dementia was 19.3 for men and 20.9 for women. The corresponding rates for VD were 12.2 for men and 9.0 for women, and for AD, 5.1 for men and 10.9 for women. Among the VD subjects whose brain morphology we examined, the most frequent type of stroke was multiple lacunar infarcts (42%), but half these subjects lacked a stroke episode in their histories. Multivariate analysis showed that age, prior stroke episodes, systolic blood pressure, and alcohol consumption were significant independent risk factors for the occurrence of VD. In contrast, age and a low score on Hasegawa's dementia scale were significant risk factors for AD, and physical activity was a significant preventive factor for AD.(ABSTRACT TRUNCATED AT 250 WORDS)
To elucidate the effect of glucose intolerance on cardiovascular disease in the current Japanese population, we performed a 75-g oral glucose tolerance test in 2,427 Hisayama residents aged 40-79 years in 1988, who were free from a previous history of stroke or myocardial infarction, and followed them prospectively for 5 years. The prevalence of diabetes (NIDDM) among men was 13% and that of impaired glucose tolerance (IGT) was 20%; the corresponding values for women were 9 and 19%, respectively. The age- and sex-adjusted incidence of cerebral infarction (6.5 per 1,000 person-years, P < 0.01) and coronary heart disease (5.0 per 1,000 person-years, P < 0.05) was significantly higher in subjects with NIDDM than in those with normal glucose tolerance (1.9 and 1.6 per 1,000 person-years, respectively). In addition, subjects with IGT and NIDDM had a higher risk of cardiovascular disease including stroke and coronary heart disease than did those with normal glucose tolerance after adjustment for age and sex, namely the relative risk for IGT was 1.9 (95% CI 1.2-3.2), and the relative risk for NIDDM was 3.0 (95% CI 1.8-5.2). These associations remained significant even after controlling for six other risk factors including hypertension in multivariate analysis. Our data suggest that NIDDM is a significant risk factor for both cerebral infarction and coronary heart disease and also that IGT itself is a risk factor for cardiovascular disease in the general Japanese population today.
We determined the population-based prevalence of diabetes mellitus in members of the Japanese community, Hisayama aged 40-79 years old by a 75-g oral glucose tolerance test. The basic population used to calculate diabetic prevalence was 1,077 men (72.8% of the whole population in the same age range) and 1,413 women (80.8%) including ten diabetic patients on insulin therapy. In addition, we compared the prevalence of history of diabetes which was acquired by interview or questionnaire, between participants and non-participants in the 75-g oral glucose tolerance test, but they were not statistically different. The age-adjusted prevalence of diabetes to world population was 12.7% for men and 8.4% for women, and that of impaired glucose tolerance was 19.6% for men and 18.4% for women. These figures were much higher than those previously reported from several Japanese communities. The results obtained from the present study could reveal true prevalence of diabetes among the Japanese population. In addition, the reasons for the increasing prevalence of diabetes among the recent Japanese population are also discussed.
We compared type-specific prevalences of dementia between two surveys of Hisayama residents ≥ 65 years old conducted in 1985 and 1992. The overall age-adjusted prevalence was greatly decreased from 5.4% in 1985 to 3.3% in 1992 for men, while it was changed little from 7.5 to 6.3% for women. The prevalence of vascular dementia (VD) decreased during the intervening 7 years in men but not in women. The prevalence of Alzheimer’s type (SDAT) was the same in either sex. The ratio of VD to SDAT prevalence was 1.8 in 1985 but fell to 1.1 in 1992. The background factors responsible for this change are discussed.
Results: With the1 min. irradiation, the neutron yield from brass is about a factor of 3 lower than that of W, and the decay of activities is about 10 times faster. For the second simulation, the neutron activity builds up slowly in brass, from about 7x10 3 Bq/cm 3 at the end of week one to a maximum of 10 4 Bq/cm 3 at the end of week 7. For W, the neutron activity builds up slowly from about 5.5x10 6 Bq/cm 3 at the end of week one, to about 9x10 6 Bq/cm 3 (0.24 mCi) at the end of week 5. The neutron activities at the beginning of the week (during irradiation) are due to nuclides with atomic numbers in the range Z = 8 -78. At the end of the week, the neutron activities are mostly due to nuclides in the range Z = 60-78, and a smaller contribution from nuclides in the range Z = 20-60. Conclusions: Our simulation showed that brass results in much lower neutron production than W. Although neutron activity slowly builds up in W, the activity is only about 0.24 mCi after 5 weeks at the surface of the metal. At the patient level, the activity will be smaller due to inverse square law. Our next step is to simulate a realistic treatment schedule with a commercial MLC to more accurately predict the neutron activities.Purpose/Objective(s): The purpose of this study is to clarify the incidence, the risk factors, and the dose-volume relationship of radiation induced rib fracture after hypofractionated stereotactic body radiation therapy (SBRT). consecutive patients treated with hypofractionated SBRT for primary or metastatic lung cancer were reviewed. The inclusion criteria were at least 3 months of follow-up by CT scan and no previous overlapped radiation exposure. Radiation induced rib fractures were defined as rib fractures located in the radiation field, detected by CT scan after treatment. The risk factors considered; age, gender, GTV diameter, chest wall -tumor distance were reviewed and each parameter was divided into two groups. Dose-volume histogram analysis was conducted on ribs received over 20 Gy at maximal point dose. The max dose and absolute volume received; $10 Gy, $20 Gy, $30 Gy and $40 Gy were determined for each ribs as the dosimetric parameters. The 3-and 5-year Kaplan-Meier (KM) estimates of rib fracture were calculated. Each risk factor was assessed by a log-rank test. The optimal cut off value for each dosimetric parameter was analyzed through the use of receiver-operating characteristic (ROC) curves. The area under the curve (AUC) values were also calculated. To estimate the cumulative risk of fracture, the ribs were divided into two groups according to the cutoff value and compared by log-rank test. S136 I. J. Radiation Oncology d Biology d Physics Volume 78, Number 3, Supplement, 2010 Results: From 129 patients, 409 ribs met the inclusion criteria. Median follow-up period was 19 months. Among the 129 patients, 26 patients (44 ribs) experienced radiation induced rib fractures. The KM estimates of rib fracture at 3 years and 5 years were 35.3%, 53.7%, respectively. As a risk factor, chest wall -tumor d...
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
customersupport@researchsolutions.com
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.